Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

被引:134
作者
Reich, EE
Markesbery, WR
Roberts, LJ
Swift, LL
Morrow, JD
Montine, TJ
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Ctr Mol Toxicol, Nashville, TN 37232 USA
[6] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[7] Univ Kentucky, Dept Pathol, Lexington, KY USA
[8] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
D O I
10.1016/S0002-9440(10)63968-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Isoprostanes (IsoP) are produced exclusively from free radical damage to arachidonic acid, a fatty acid that is evenly distributed throughout white matter and gray matter, whereas neuroprostanes (NPs) are generated analogously from docosahexaenoic acid (DHA), a fatty acid enriched in gray matter where it is concentrated in neurons. IsoP and NPs derive from endoperoxide intermediates that isomerize to D/E-ring forms or that are reduced to F-ring compounds. We quantified F-ring and D/E-ring IsoP and NPs in temporal and parietal cortex, hippocampus, and cerebellum of nine definite Alzheimer's disease (AD) patients and 11 age-matched controls. Total NP levels (F-ring plus D/E-ring), but not total IsoP, were significantly greater in AD than controls (P < 0.0001); only cerebral regions in AD patients had NPs greater than controls (P < 0.05), The F-ring to D/E-ring ratio for NPs, but not IsoP, was 40 to 70% lower in all brain regions of AD patients compared to controls (P < 0.005), These data extend results from in situ techniques, that have localized reactive products of lipid peroxidation primarily to neurons, by quantifying significantly greater free radical damage to the DHA-containing compartments in cerebrum in AD patients than controls, and suggest that one mechanism of increased oxidative stress may be diminished reducing capacity in DHA-containing compartments.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 32 条
  • [1] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [2] THE MEASUREMENT AND MECHANISM OF LIPID-PEROXIDATION IN BIOLOGICAL-SYSTEMS
    GUTTERIDGE, JMC
    HALLIWELL, B
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (04) : 129 - 135
  • [3] Markesbery WR, 1999, BRAIN PATHOL, V9, P133
  • [4] MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
  • [5] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE
    MIRRA, SS
    HEYMAN, A
    MCKEEL, D
    SUMI, SM
    CRAIN, BJ
    BROWNLEE, LM
    VOGEL, FS
    HUGHES, JP
    VANBELLE, G
    BERG, L
    [J]. NEUROLOGY, 1991, 41 (04) : 479 - 486
  • [6] 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease
    Montine, KS
    Kim, PJ
    Olson, SJ
    Markesbery, WR
    Montine, TJ
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (08) : 866 - 871
  • [7] Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
    Montine, KS
    Reich, E
    Neely, MD
    Sidell, KR
    Olson, SJ
    Markesbery, WR
    Montine, TJ
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05) : 415 - 425
  • [8] Montine KS, 1997, AM J PATHOL, V150, P437
  • [9] The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
    Montine, TJ
    Markesbery, WR
    Zackert, W
    Sanchez, SC
    Roberts, LJ
    Morrow, JD
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) : 863 - 868
  • [10] Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease
    Montine, TJ
    Markesbery, WR
    Morrow, JD
    Roberts, LJ
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 410 - 413